Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

NetScientific hails commercial launch of breakthrough cancer detection device

The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
NetScientific hails commercial launch of breakthrough cancer detection device
The fully-automated technology is able to collect circulating tumour cells
NetScientific PLC (LON:NSCI) said its investee company Vortex Biosciences has begun the commercial launch of its VTX1 Liquid Biopsy System.
 
The fully-automated technology offers a breakthrough in early cancer detection in that it is able to collect circulating tumour cells (CTC) from the bloodstream that provide the tell-tale sign of the killer disease.
 
"We believe the technology has several key advantages over current approaches to CTC isolation and has the potential to make a meaningful impact on cancer research and assist the development of innovative diagnostics and therapeutics," said NetScientific chief executive François Martelet. 
 
"The commercial launch is a critical milestone for Vortex and brings our portfolio company closer to significant value creation."
 
The AIM-listed investment company owns 95% of Votex having invested just over £13mln in the business.
 
The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
 
Ian_55ae0ddd437b7.jpg
Why Invest In Netscientific PLC? Read More Here

Register here to be notified of future NSCI Company articles
View full NSCI profile

Netscientific PLC Timeline

Related Articles

Novogen: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Dr James Garner talked clinical-stage programs with investors.
Pollen2.jpg
January 19 2017
Turnover was £40.4mln in the six months to December
Concept of a DNA strand
February 14 2017
Proactive Investors takes a closer look at an AIM-listed biotech firm that is making advances altering the inner workings of the human body to tackle deadly diseases

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use